|
DCP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.26030000002775E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55155000000073E-05 |
| Normal-vs-Stage2 |
3.42490000027063E-07 |
| Normal-vs-Stage3 |
4.55160000001342E-06 |
| Normal-vs-Stage4 |
2.46589999974844E-07 |
| Stage1-vs-Stage2 |
5.208100E-02 |
| Stage1-vs-Stage3 |
5.841600E-01 |
| Stage1-vs-Stage4 |
5.060300E-02 |
| Stage2-vs-Stage3 |
1.800420E-01 |
| Stage2-vs-Stage4 |
9.706800E-01 |
| Stage3-vs-Stage4 |
1.792160E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.24699999998401E-06 |
| Normal-vs-AfricanAmerican |
6.041999999995E-05 |
| Normal-vs-Asian |
5.68960000000285E-05 |
| Caucasian-vs-AfricanAmerican |
8.949800E-01 |
| Caucasian-vs-Asian |
9.750800E-01 |
| AfricanAmerican-vs-Asian |
9.044000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.03079999999889E-05 |
| Normal-vs-Female |
6.60049999989809E-07 |
| Male-vs-Female |
1.479410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.14739999999858E-05 |
| Normal-vs-Age(41-60Yrs) |
2.97289999950934E-07 |
| Normal-vs-Age(61-80Yrs) |
1.03620000002635E-06 |
| Normal-vs-Age(81-100Yrs) |
2.515400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.652400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.432400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.120200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.463400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.156100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.397360E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.225600E-01 |
| Classical-VS-Follicular |
4.87000000326532E-08 |
| Classical-VS-Other |
1.909800E-01 |
| Classical-VS-Normal |
7.64779999999909E-05 |
| Tall-VS-Follicular |
9.379700E-02 |
| Tall-VS-Other |
6.792000E-01 |
| Tall-VS-Normal |
5.59849999999251E-05 |
| Follicular-VS-Other |
6.357200E-01 |
| Follicular-VS-Normal |
1.50629997364149E-09 |
| Other-VS-Normal |
1.631840E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.66849999991581E-07 |
| Normal-vs-N1 |
4.23869999988113E-07 |
| N0-vs-N1 |
5.859000E-01 |
|
|
